111 – 120 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Do we have blind spots in our diagnostic vision?
(
- Contribution to journal › Letter
-
Mark
From biomarker to surrogate outcome to osteoarthritis--what are the challenges?
(
- Contribution to journal › Article
-
Mark
Concomitant therapy : an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials
(
- Contribution to journal › Article
- 2004
-
Mark
Markers of altered metabolism in osteoarthritis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Features associated with epilepsy in the antiphospholipid syndrome
(
- Contribution to journal › Article
-
Mark
CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome.
(
- Contribution to journal › Article
-
Mark
Septicemia with Staphylococcus aureus, beta-hemolytic streptococei group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)
(
- Contribution to journal › Letter
-
Mark
Markers of Altered Metabolism in Osteoarthritis
2004) International Workshop on Osteoarthritis Outcomes In Journal of Rheumatology 31(Suppl. 70). p.28-35(
- Contribution to journal › Article
-
Mark
Prevalence of current and chronic pain and their influences upon work and healthcare-seeking: A population study
(
- Contribution to journal › Article
- 2003
-
Mark
Principles of bone and joint disease control programs - osteoporosis.
(
- Contribution to journal › Article